ILMN
Illumina, Inc.
$188.68
+4.79 (+2.60%)
At close · Jul 2
Market Cap
$28.55B
Shares
151,300,000
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Daniel M. Skovronsky, M.D., Ph.D. | Director | Appointed | 2026-06-23 |
Key facts
CIK
1110803
CUSIP
452327109
13F (30d)
60 filings
15 filers
Visit website
Investor relations